These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1912 related items for PubMed ID: 19268410

  • 21. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
    Duncan N, Dhaygude A, Owen J, Cairns TD, Griffith M, McLean AG, Palmer A, Taube D.
    Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
    [Abstract] [Full Text] [Related]

  • 22. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 23. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 15; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 24. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
    Pol Merkur Lekarski; 2005 Feb 15; 18(104):168-72. PubMed ID: 17877123
    [Abstract] [Full Text] [Related]

  • 25. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Feb 15; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 26. Treatment of steroid resistant nephrotic syndrome in children.
    Kari JA, Halawani M.
    Saudi J Kidney Dis Transpl; 2010 May 15; 21(3):484-7. PubMed ID: 20427873
    [Abstract] [Full Text] [Related]

  • 27. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
    Matsumoto H, Nakao T, Okada T, Nagaoka Y, Shino T, Yoshino M, Hidaka H.
    Clin Nephrol; 2001 Feb 15; 55(2):143-8. PubMed ID: 11269678
    [Abstract] [Full Text] [Related]

  • 28. [Long-term effects of cyclosporine A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients].
    Cao Q, Huang WY, Xu H, Zhou LJ.
    Zhonghua Er Ke Za Zhi; 2008 Sep 15; 46(9):698-701. PubMed ID: 19099862
    [Abstract] [Full Text] [Related]

  • 29. Steroid resistant nephrotic syndrome: role of histopathology.
    Gulati S, Sengupta D, Sharma RK, Sharma A, Gupta RK, Singh U, Gupta A.
    Indian Pediatr; 2006 Jan 15; 43(1):55-60. PubMed ID: 16465008
    [Abstract] [Full Text] [Related]

  • 30. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
    Wyszyńska T, Ksiazek J, Wieteska-Klimczak A, Gorzkowska-Paczwa M, Dorywalski T, Tysarowska A.
    Pol Merkur Lekarski; 2001 Aug 15; 11(62):140-3. PubMed ID: 11757213
    [Abstract] [Full Text] [Related]

  • 31. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.
    Chin Med J (Engl); 2001 Dec 15; 114(12):1305-8. PubMed ID: 11793859
    [Abstract] [Full Text] [Related]

  • 32. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome.
    Iyengar A, Karthik S, Kumar A, Biswas S, Phadke K.
    Indian Pediatr; 2006 Jan 15; 43(1):14-9. PubMed ID: 16465001
    [Abstract] [Full Text] [Related]

  • 33. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
    Meyrier A.
    J Nephrol; 1997 Jan 15; 10(1):14-24. PubMed ID: 9241620
    [Abstract] [Full Text] [Related]

  • 34. Comparison between pre- and posttreatment clinical and renal biopsies in children receiving low dose ciclosporine-A for 2 years for steroid-dependent nephrotic syndrome.
    Kano K, Kyo K, Yamada Y, Ito S, Ando T, Arisaka O.
    Clin Nephrol; 1999 Jul 15; 52(1):19-24. PubMed ID: 10442491
    [Abstract] [Full Text] [Related]

  • 35. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO.
    Transplant Proc; 2009 Jul 15; 41(6):2659-63. PubMed ID: 19715995
    [Abstract] [Full Text] [Related]

  • 36. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.
    Pediatr Int; 2015 Jul 15; 57(1):85-91. PubMed ID: 25225083
    [Abstract] [Full Text] [Related]

  • 37. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May 15; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

  • 38. Tacrolimus rescue therapy in resistant or relapsing cases of primary glomerulonephritis.
    Arikan H, Koc M, Cakalagaoglu F, Eren Z, Segal MS, Tuglular S, Ozener C, Akoglu E.
    J Nephrol; 2008 May 15; 21(5):713-21. PubMed ID: 18949726
    [Abstract] [Full Text] [Related]

  • 39. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May 15; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 40. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov 15; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 96.